Drugs / AL 721
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001012 | — | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AL-721 | “AL-721 is a mixture of lipids (fats) extracted from egg yolks.” NCT00001012 ↗ |
| Action | Inhibit | “it might inhibit the infectivity of the HIV.” NCT00001012 ↗ |
| Modality | Other / unclassified | “AL-721 is a mixture of lipids (fats) extracted from egg yolks.” NCT00001012 ↗ |